ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹18 Cr | ₹-19 Cr | ₹18 Cr | ₹-11 Cr | ₹-74 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ORCHID PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹-11 Cr |
| Mar2021 | ₹-74 Cr |
How is Net Cash Inflow / Outflow of ORCHID PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹18 Cr | Positive | |
| Mar2022 | ₹-11 Cr | Negative | |
| Mar2021 | ₹-74 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,024.4 Cr | -1.9% | 38.5% | 43% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -1.9% |
38.5% |
43% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses